Company Profile
Lixte Biotechnology Holdings Stock Price, News & Analysis
- Ticker:
- LIXT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Lixte Biotechnology Holdings is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
7.30 USD (-2.41%)
Close
Last updated: June 23, 2026 at 00:00
126.92M USD
Market cap
Why the stock is moving
LIXT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Lixte Biotechnology Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Lixte Biotechnology Holdings is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Lixte Biotechnology Holdings follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Lixte Biotechnology Holdings sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
Source: Lixte Biotechnology Holdings
- 02
- 03
- 04
- 05
LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update
Source: Lixte Biotechnology Holdings
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Lixte Biotechnology Holdings (LIXT)?
Lixte Biotechnology Holdings (LIXT) most recently closed at 7.30 USD, a -2.41% move versus the previous session.
What is the market cap of Lixte Biotechnology Holdings (LIXT)?
Lixte Biotechnology Holdings currently has a market capitalization of 126.92M USD on BioPharmSignal.
What does Lixte Biotechnology Holdings do?
Lixte Biotechnology Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is LIXT stock listed?
Lixte Biotechnology Holdings (LIXT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Lixte Biotechnology Holdings is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Lixte?
Lixte Biotechnology Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Lixte Biotechnology Holdings targeting with Lixte?
Lixte Biotechnology Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biotechnology?
Lixte Biotechnology Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Holdings?
Lixte Biotechnology Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.